Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1614 1626 1628 1629 1642 1691
This examiner grants 80% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18523284 | HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS | Non-Final OA | Genentech, Inc. |
| 18572741 | Degrader Compounds and Uses Thereof | Non-Final OA | ABBVIE INC. |
| 18024662 | TREATMENT OF VASCULAR EHLERS-DANLOS SYNDROME AND RELATED SYNDROMES | Non-Final OA | The Johns Hopkins University |
| 18568401 | Method for Producing Fluorescent Probe Library Using Solid-Phase Extraction and Method of Measuring Enzyme Activity Using Same | Non-Final OA | RIKEN |
| 18526010 | METHOD FOR ALLEVIATING UTERINE LEIOMYOMA USING NICOTINAMIDE | Non-Final OA | TAIPEI MEDICAL UNIVERSITY |
| 18525177 | TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF IN A SUBJECT HAVING INFLUENZA AND A COMPLICATION RISK FACTOR | Non-Final OA | Shionogi & Co., Ltd. |
| 18572676 | DERIVATIVES OF THE PROTECTIN 10S,17S-DIHDA (PDX) AND USE THEREOF AS ANTIVIRAL, ANTI-INFLAMMATORY, AND ANTI-DIABETIC AGENTS | Non-Final OA | UNIVERSITÉ LAVAL |
| 18580864 | COMPOSITIONS COMPRISING OTESECONAZOLE | Non-Final OA | Mycovia Pharmaceuticals, Inc. |
| 18400508 | PROCESS FOR SYNTHESIZING 2-BROMOLYSERGIC ACID DIETHYLAMIDE VIA CONTROLLED HYDROLYSIS OF BROMOCRIPTINE | Non-Final OA | Ceruvia Lifesciences LLC |
| 18263196 | PREVENTIVE OR THERAPEUTIC AGENT FOR INFLAMMATORY DISORDERS AND/OR PAIN DISORDERS | Non-Final OA | Kyowa Pharma Chemical Co., Ltd. |
| 18501307 | 4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF | Non-Final OA | Biosplice Therapeutics, Inc. |
| 18287885 | IDH MUTANT INHIBITOR AND USE THEREOF | Non-Final OA | WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD. |
| 18287329 | GOLEXANOLONE FOR USE IN THE TREATMENT OF FATIGUE OR COGNITIVE IMPAIRMENT IN LIVER DISEASE PATIENTS | Non-Final OA | Umecrine Cognition AB |
| 18278063 | S-CONFIGURATION-CONTAINING AMINO BENZAMIDE PYRIDAZINONE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Non-Final OA | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES |
| 18554241 | COMBINATIONS OF LSD1 INHIBITORS FOR TREATING MYELOID CANCERS | Non-Final OA | ORYZON GENOMICS, S.A. |
| 18273841 | AMORPHOUS FORM OF BISMUTH-1,2-ETHANEDITHIOL AND METHODS OF MAKING | Non-Final OA | Microbion Corporation |
| 18550790 | COMPOSITIONS OF MICRONIZED SOLABEGRON AND METHODS OF USE | Non-Final OA | B3AR THERAPEUTICS, INC. |
| 18280837 | COMPOSITIONS AND METHODS FOR TREATING POLYCYTHEMIA | Non-Final OA | Disc Medicine, Inc. |
| 18274483 | PRETOMANID AMORPHOUS FORM | Non-Final OA | THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. |
| 18547587 | EMULSION FOR USE IN THE TREATMENT OF ROSACEA | Non-Final OA | EXINOV |
| 18278078 | INHIBITORS OF EPHB3 SIGNALING | Final Rejection | The Brigham and Women`s Hospital, Inc. |
| 18361080 | STABLE PHARMACEUTICAL ORAL LIQUID FORMULATION OF AN ANTISPASMODIC AGENT | Non-Final OA | Sushma Paul BERLIA |
| 18256545 | METHODS OF ADMINISTERING SYNTHETIC TRITERPENOIDS | Final Rejection | REATA PHARMACEUTICALS HOLDINGS, LLC |
| 18026780 | Novel Formulations of Psilocybin And Psilocin Compounds as Serotonin Agonists in Combination With 3,4 Methylenedioxymethamphetamine (MDMA) | Non-Final OA | Mydecine Innovations Group Inc. |
| 18182153 | METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS | Non-Final OA | EpicentRx, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy